Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.
You are here: Home / Nvidia invests $50 million in biotech company Recursion for A.I. drug discovery
Market News and Views
Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.